The pathogenesis of obstetric APS: a 2023 update
Clinical Immunology · 2023-10 · 255 · 109745
DOI: 10.1016/j.clim.2023.109745 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Immunology, 2023-10. Verfasst von Chieko Mineo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pulmonary and Vascular Biology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, United States. Electronic address: c…. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Antibodies, Antiphospholipid. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NICHD NIH HHS, NIH.
Abstract (Originalsprache)
The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the persistent presence of antibodies directed against phospholipids and phospholipid-binding proteins that are associated with thrombosis and pregnancy-related morbidity. The latter includes fetal deaths, premature birth and maternal complications. In the early 1990s, a distinct set of autoantibodies, termed collectively antiphospholipid antibodies (aPL), were identified as the causative agents of this disorder. Subsequently histological analyses of the placenta from APS pregnancies revealed various abnormalities, including inflammation at maternal-fetal interface and poor placentation manifested by reduced trophoblast invasion and limited uterine spiral artery remodeling. Further preclinical investigations identified the molecular targets of aPL and the downstream intracellular pathways of key placental cell types. While these discoveries suggest potential therapeutics for this disorder, definitive clinical trials have not been completed. This concise review focuses on the recent developments in the field of basic and translational research pursuing novel mechanisms underlying obstetric APS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pulmonary and Vascular Biology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, United States. Electronic address: chieko.mineo@utsouthwestern.edu.
- Center for Pulmonary and Vascular Biology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, United States.
- Division of Rheumatic Diseases, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Förderung
- American Heart Association-American Stroke Association
- NICHD NIH HHS
- NIH
- American Heart Association
Zitieren
APA
Mineo, C., Shaul, P. W., & Bermas, B. L. (2023). The pathogenesis of obstetric APS: a 2023 update. Clinical Immunology, 255, 109745. https://doi.org/10.1016/j.clim.2023.109745
Vancouver
Mineo C, Shaul PW, Bermas BL. The pathogenesis of obstetric APS: a 2023 update. Clinical Immunology. 2023;255:109745. doi:10.1016/j.clim.2023.109745
BibTeX
@article{Mineo2023,
author = {Mineo, Chieko and Shaul, Philip W and Bermas, Bonnie L},
title = {The pathogenesis of obstetric APS: a 2023 update},
journal = {Clinical Immunology},
year = {2023},
volume = {255},
pages = {109745},
doi = {10.1016/j.clim.2023.109745}
}
EUVIMED